| 000 | 01559 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514191749.0 | ||
| 264 | 0 | _c20040729 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0804-4643 | ||
| 024 | 7 |
_a10.1530/eje.0.1500793 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiamanti-Kandarakis, Evanthia | |
| 245 | 0 | 0 |
_aThe prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. _h[electronic resource] |
| 260 |
_bEuropean journal of endocrinology _cJun 2004 |
||
| 300 |
_a793-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aBody Constitution |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xblood |
| 650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xblood |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 700 | 1 | _aPalioniko, Gaetano | |
| 700 | 1 | _aAlexandraki, Krystallenia | |
| 700 | 1 | _aBergiele, Angeliki | |
| 700 | 1 | _aKoutsouba, Thenia | |
| 700 | 1 | _aBartzis, Michael | |
| 773 | 0 |
_tEuropean journal of endocrinology _gvol. 150 _gno. 6 _gp. 793-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/eje.0.1500793 _zAvailable from publisher's website |
| 999 |
_c14898109 _d14898109 |
||